30
Views
16
CrossRef citations to date
0
Altmetric
Original

A pilot study showing an association between platelet hyperactivity and the severity of peripheral arterial disease

, , &
Pages 245-248 | Received 09 Oct 2006, Accepted 20 Oct 2006, Published online: 07 Jul 2009
 

Abstract

Peripheral arterial disease (PAD) is a chronic fibroproliferative inflammatory condition associated with progressive vascular stenosis. We set out to determine the relationship between spontaneous stirring-induced platelet aggregation in whole blood and the severity of lower-limb PAD, represented by the ankle-brachial pressure index (ABPI). ABPI was determined pre- and post-exercise in 31 subjects (20 men and 11 women) with established PAD. Platelets counts were determined in EDTA blood (total count) and in citrated whole blood after stirring in the absence of added ADP (spontaneous aggregation) and in the presence of added ADP (ADP-induced) for 3 min at 37°C. Aggregation was calculated as a percentage of the total platelet count. Spontaneous platelet aggregation showed an inverse correlation with pre-exercise ABPI (r = −0.32; P < 0.05) and ADP-induced aggregation correlated inversely with post-exercise ABPI (r = −0.34; P < 0.05). These results indicate that platelet hyperactivity is associated with increasing severity of PAD. Increased platelet aggregation may result in thromboembolic events in the affected limb.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.